PAPER Vecchio F, Miraglia F, Marra C, Quaranta D, Vita MG, Bramanti P, Rossini PM
SEARCH RESULTS
330988 RESULTS
PAPER Song G, Zhang Z, Wen L, Chen C, Shi Q, Zhang Y, Ni J, Liu Q
Selenomethionine ameliorates cognitive decline, reduces tau hyperphosphorylation, and reverses synaptic deficit in the triple transgenic mouse model of Alzheimer's disease.
J Alzheimers Dis. 2014;41(1):85-99. PubMed: 24577479PAPER Bolognin S, Cozzi B, Zambenedetti P, Zatta P
Metallothioneins and the central nervous system: from a deregulation in neurodegenerative diseases to the development of new therapeutic approaches.
J Alzheimers Dis. 2014;41(1):29-42. PubMed: 24577478PAPER Silverstein JH
Influence of anesthetics on Alzheimer's disease: biophysical, animal model, and clinical reports.
J Alzheimers Dis. 2014;40(4):839-48. PubMed: 24577477PAPER Teipel SJ, Grothe MJ, Filippi M, Fellgiebel A, Dyrba M, Frisoni GB, Meindl T, Bokde AL, Hampel H, Klöppel S, Hauenstein K, EDSD study group
Fractional anisotropy changes in Alzheimer's disease depend on the underlying fiber tract architecture: a multiparametric DTI study using joint independent component analysis.
J Alzheimers Dis. 2014;41(1):69-83. PubMed: 24577476PAPER Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC
Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis.
J Alzheimers Dis. 2014;41(1):151-61. PubMed: 24577475PAPER Walton JR
Chronic aluminum intake causes Alzheimer's disease: applying Sir Austin Bradford Hill's causality criteria.
J Alzheimers Dis. 2014;40(4):765-838. PubMed: 24577474PAPER Zimmermann R, Huber E, Schamber C, Lelental N, Mroczko B, Brandner S, Maler JM, Oberstein T, Szmitkowski M, Rauh M, Kornhuber J, Lewczuk P
Plasma concentrations of the amyloid-β peptides in young volunteers: the influence of the APOE genotype.
J Alzheimers Dis. 2014;40(4):1055-60. PubMed: 24577473PAPER de Oliveira J, Moreira EL, dos Santos DB, Piermartiri TC, Dutra RC, Pinton S, Tasca CI, Farina M, Prediger RD, de Bem AF
Increased susceptibility to amyloid-β-induced neurotoxicity in mice lacking the low-density lipoprotein receptor.
J Alzheimers Dis. 2014;41(1):43-60. PubMed: 24577472PAPER Haller S, Montandon ML, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Lovblad KO, Giannakopoulos P
Acute caffeine administration effect on brain activation patterns in mild cognitive impairment.
J Alzheimers Dis. 2014;41(1):101-12. PubMed: 24577471PAPER Rábano A, Rodal I, Cuadros R, Calero M, Hernández F, Ávila J
Argyrophilic grain pathology as a natural model of tau propagation.
J Alzheimers Dis. 2014;40 Suppl 1:S123-33. PubMed: 24577470PAPER Troussière AC, Wallon D, Mouton-Liger F, Yatimi R, Robert P, Hugon J, Hannequin D, Pasquier F, Paquet C
Who needs cerebrospinal biomarkers? A national survey in clinical practice.
J Alzheimers Dis. 2014;40(4):857-61. PubMed: 24577469PAPER de Cristóbal J, García-García L, Delgado M, Pérez M, Pozo MA, Medina M
Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging.
J Alzheimers Dis. 2014;40 Suppl 1:S79-89. PubMed: 24577468PAPER Gharbiya M, Trebbastoni A, Parisi F, Manganiello S, Cruciani F, D'Antonio F, De Vico U, Imbriano L, Campanelli A, De Lena C
Choroidal thinning as a new finding in Alzheimer's disease: evidence from enhanced depth imaging spectral domain optical coherence tomography.
J Alzheimers Dis. 2014;40(4):907-17. PubMed: 24577467PAPER Balasa M, Sánchez-Valle R, Antonell A, Bosch B, Olives J, Rami L, Castellví M, Molinuevo JL, Lladó A
Usefulness of biomarkers in the diagnosis and prognosis of early-onset cognitive impairment.
J Alzheimers Dis. 2014;40(4):919-27. PubMed: 24577466Current Filters
No filters selected